Deep Tech Startups

Climeworks develops Direct Air Capture technology to remove carbon dioxide directly from the air, and through Climeworks Solutions designs and manages carbon removal portfolios that combine engineered and nature-based methods. It serves organizations seeking carbon removal, including compliance-ready offerings.

4 investors

Comind is developing non-invasive neurotechnology that measures a range of neurophysiological brain signals in a single bedside measurement. The technology is aimed at doctors and clinical care settings to support patient assessment and treatment.

4 investors

Corephotonics develops multi-aperture camera technologies for smartphones and mobile devices, including lens and actuator design, camera hardware, and image processing software. It serves mobile device manufacturers, integrating its cameras and software across mobile computing platforms.

4 investors

Cortical Labs develops biological computing systems by growing human neurons on chips to create a programmable computing platform. The company serves researchers and innovators seeking to accelerate medical research, reduce energy consumption in computing, and enable alternatives to animal testing.

4 investors

Creative Destruction Lab (CDL) is a global startup program for seed-stage, science-based companies that pairs founders with experienced entrepreneurs, angel investors, economists, and scientists through an objectives-based mentoring process. Affiliated with the University of Toronto's Rotman School of Management, it operates across multiple university sites worldwide with streams in areas such as AI, quantum, climate, and fintech.

4 investors

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease. It pairs this delivery technology with an AI/ML nucleic acid engineering platform (NucleIQ) to design nucleic acid therapies.

4 investors

CubaseBio develops spatial biology tools that enable three-dimensional analysis of biological samples at scale, for drug discovery and biological research.

4 investors

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia. Its lead drug targets a specific subunit of the GABA-A receptor to improve neuronal function and reverse cognitive impairment.

4 investors

Deep Sky develops carbon removal technology, leveraging geological expertise and subsurface engineering to address climate change. The company operates with teams of geologists, climate scientists, and software engineers across multiple countries.

4 investors

DeepLife is an AI techbio company that develops digital twin technology to simulate cellular behavior and disease mechanisms at the single-cell level. The platform integrates multi-omics data and causal AI to accelerate drug discovery and development for diseases with significant unmet medical needs.

4 investors

Diamond Foundry produces lab-grown diamond and diamond wafers for use as a semiconductor material, aiming to enable diamond transistors and electronics. It targets thermal-management challenges in applications such as AI computing, electric vehicles, and wireless technology.

4 investors

DiaMonTech develops a non-invasive, painless optical technology for measuring blood glucose within seconds, offered as a handheld device (still in development), a miniaturized sensor for wearables such as smartwatches (developed with Samsung), and a companion app for tracking glucose, blood pressure, nutrition, activity, weight and medication. The company targets diabetes management and life-sciences applications.

4 investors

Downforce Technologies operates a data-driven platform that measures soil organic carbon, soil health and biodiversity using high-resolution remote data instead of physical soil sampling. It serves farmers, landowners and agricultural, food and fashion supply chains for carbon monitoring, regenerative farming, and sustainability reporting and compliance.

4 investors

Duality develops simulation software that models complex environmental scenarios and processes real-time sensor and machine data. The company serves industries requiring accurate digital simulations for operational insights.

4 investors

Dunia operates an autonomous materials acceleration platform called IRIS that combines robotics, AI foundation models, and experimental data to speed up the discovery of new materials, beginning with energy applications. The platform generates large-scale, reproducible materials datasets to train AI models and shorten R&D timelines.

4 investors

Dust Identity uses engineered diamond-dust to create discreet, clone-proof object markers, each tied to a digital record that tracks the object over its lifespan. The technology provides material integrity and product authentication for brands, manufacturers, OEMs, and collectors across the supply chain.

4 investors

Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells. The company focuses on oncology diagnostics and therapeutics for cancer patients.

4 investors

Eclipsebio provides RNA biology analytical services and sequencing-based assays that help drug developers and researchers characterize RNA at nucleotide-level resolution and generate datasets for AI-driven drug discovery. It serves pharma, biotech, and academic partners working on oligonucleotides, RNA-targeting small molecules, and fundamental RNA research.

4 investors

Edge Sound Research builds intelligent audio infrastructure based on patented technologies that capture, separate, and enhance sound, transform physical surfaces into sound emitters, and map audio into spatial experiences. It licenses these technologies to partners for applications requiring audio clarity, analysis, and real-time decision-making.

4 investors

EFFECT Photonics designs integrated tunable laser assemblies (pico and nano ITLAs) built on a monolithic indium phosphide photonic integration platform for coherent optical transceivers used in telecom, metro, access, DCI and AI networks. A fabless spin-off from Eindhoven University of Technology, it supplies production-grade photonic components to optical network programs.

4 investors

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

4 investors

Element Energy develops an adaptive battery management system that improves safety, longevity, and energy output for battery packs through cell-level monitoring and management algorithms.

4 investors

ElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.

4 investors

Emerald Cloud Lab (ECL) provides remote, cloud-based access to a life science research laboratory, letting researchers run and automate experiments and workflows without a physical lab. It serves pharmaceutical, biotech, consumer products, academic, and contract research organizations across applications such as discovery, CMC, DMPK, and diagnostics.

4 investors